NIH-funded research NIH-funded research

Improving survival rates after out-of-hospital cardiac arrest through better medication timing and delivery

Official title: Optimizing the Timing and Route of Antiarrhythmic Administration in Out-of-Hospital Cardiac Arrest

Funded at Oregon Health & Science University · NIH-10864721 · Data updated 2026-11-12

This study is looking at whether giving a heart medication called amiodarone sooner and in a different order can help people who have a cardiac arrest due to certain heart rhythms, with the goal of improving their chances of survival and recovery.

More Cardiac Arrest research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionOregon Health & Science University
NIH-funded
Lab location1 site (Portland, United States)
Project startJuly 1, 2024
Project endJune 30, 2029
Funding year2024
Award (this year)$191,365
NIH project number1K23HL173647-01
Project IDNIH-10864721 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have experienced out-of-hospital cardiac arrest due to ventricular fibrillation or pulseless ventricular tachycardia.

Less likely to help

Patients who have cardiac arrest due to causes other than ventricular fibrillation or pulseless ventricular tachycardia may not benefit from this research.

What this research studies

This research investigates how the timing and method of administering antiarrhythmic medications, specifically amiodarone, can affect survival rates in patients who experience out-of-hospital cardiac arrest due to ventricular fibrillation or pulseless ventricular tachycardia. The study aims to determine if giving these medications earlier and in a different sequence can lead to better outcomes compared to current treatment guidelines. By conducting a pilot trial, the research will assess the impact of these changes on patient survival and overall recovery. Patients experiencing cardiac arrest may benefit from this research as it seeks to optimize emergency treatment protocols.

Why it matters

Potential benefit: If successful, this research could significantly increase survival rates for patients experiencing out-of-hospital cardiac arrest.

How similar studies have gone: Previous research has shown that optimizing medication timing in emergency situations can improve patient outcomes, suggesting potential success for this approach.

Where this research is happening

  • Oregon Health & Science University
    Portland, United States
    Active

Researchers

  • Principal investigator: Lupton, Joshua — Oregon Health & Science University
  • Study coordinator: Lupton, Joshua

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.